Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Tranexamic Acid and Head and Neck Surgery Patients
This study is currently recruiting participants.
Verified by Taichung Veterans General Hospital, March 2006
Sponsors and Collaborators: Taichung Veterans General Hospital
None
Information provided by: Taichung Veterans General Hospital
ClinicalTrials.gov Identifier: NCT00308880
  Purpose

Tranexamic acid belongs to fibrinolytic inhibitors. Several prospective randomized clinical trials have proved its effectiveness in reducing intra-operative and post-operative bleeding in orthopedic and cardiovascular surgeries. However, there is little study about tranexamic acid in reducing post-operative bleeding in head and neck surgery. So the aim of this study is to investigate if tranexamic acid could reduce post-operative bleeding via prospective double-blinded randomized clinic trial.


Condition Intervention Phase
Head and Neck Neoplasms
Drug: Transamin
Phase III

MedlinePlus related topics: Cancer Head and Neck Cancer
Drug Information available for: Tranexamic acid
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study
Official Title: If Tranexamic Acid Could Reduce the Duration of Drainage Tube Placement ? —A Prospective Randomized Study in Head and Neck Surgery Patients

Further study details as provided by Taichung Veterans General Hospital:

Primary Outcome Measures:
  • Drainage amount
  • Drainage stay duration
  • Laboratoy data

Estimated Enrollment: 80
Study Start Date: March 2006
Estimated Study Completion Date: March 2007
Detailed Description:

Otolaryngologists often use drainage tube after head and neck surgery to reduce hematoma or seroma formation. In addition, the duration of drainage tube placement is closely related to the length of hospital stay. So early removal of drainage tube could eventually shorten the admission period. The factors related to the duration of drainage tube placement include: type of surgery, intra-operative bleeding, underlying disease of coagulation disorders, etc. According to the literatures, the average duration of drainage in head and neck surgery is 4 days. Another study showed that one of the risk factors associated with surgical site infection is the longer drainage duration. Therefore, how to remove drainage tube as soon as possible is crucial to head and neck surgeon.Tranexamic acid belongs to fibrinolytic inhibitors. Several prospective randomized clinical trials have proved its effectiveness in reducing intra-operative and post-operative bleeding in orthopedic and cardiovascular surgeries. However, there is little study about tranexamic acid in reducing post-operative bleeding in head and neck surgery. So the aim of this study is to investigate if tranexamic acid could reduce post-operative bleeding via prospective double-blinded randomized clinic trial.This study includes 60 consecutive patients who will undergo head and neck surgery. Those who are allergy to tranexamic acid, history of coagulation disorders, under anti-coagulation therapy will be excluded. Basic data will be recorded along with detail physical examination and operation type. Then they will be divided randomly into study group and control group. Study group will receive tranexamic acid before and after operation while control group not. PT, APTT, level of prothrombin fragments 1+2, D-dimers, plasminogen, α2-antiplasmin, tissue plasminogen activator (tPA), and plasminogen activator inhibitor (PAI-1) will be obtained before and after operation. The drainage amount, duration of drainage tube placement will also be recorded. Relevant variables will be collected and analyzed.

  Eligibility

Ages Eligible for Study:   20 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • head and neck neoplasm scheduled for operation

Exclusion Criteria:

  • allergy to tranexamic acid
  • history of coagulation disorders
  • under anti-coagulation therapy
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00308880

Contacts
Contact: Chih-Cheng Chen, MD +886-968-950005
Contact: Shih-An Liu, MD, MHA +886-936-294749 saliu@vghtc.gov.tw

Locations
Taiwan
Taichung Veterans General Hospital Recruiting
Taichung, Taiwan, 40705
Sponsors and Collaborators
Taichung Veterans General Hospital
None
Investigators
Principal Investigator: Shih-An Liu, MD, MHA Taichung Veterans General Hospital
  More Information

Study ID Numbers: TCVGH-957001A, 941117/C05186
Study First Received: March 29, 2006
Last Updated: March 29, 2006
ClinicalTrials.gov Identifier: NCT00308880  
Health Authority: Taiwan: Department of Health

Keywords provided by Taichung Veterans General Hospital:
Tranexamic acid
head neck surgery

Study placed in the following topic categories:
Antiplasmin
Head and Neck Neoplasms
Tranexamic Acid

Additional relevant MeSH terms:
Fibrin Modulating Agents
Neoplasms
Antifibrinolytic Agents
Neoplasms by Site
Coagulants
Molecular Mechanisms of Pharmacological Action
Therapeutic Uses
Hematologic Agents
Hemostatics
Pharmacologic Actions

ClinicalTrials.gov processed this record on January 14, 2009